GTX Corp Provides Corporate Update And Reports First Quarter 2015 Financial Results

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today reported financial results for the first quarter ended March 31, 2015, and highlighted recent accomplishments and upcoming milestones. The Company remains primarily focused on targeting the androgen receptor in women with advanced breast cancer using enobosarm, the Company’s oral, nonsteroidal selective androgen receptor modulator.

Help employers find you! Check out all the jobs and post your resume.